In a phase 2 trial, patients having an urticaria exacerbation who used the spray report better hive and pruritus scores than the placebo group.
Patients at risk for anaphylaxis as well as caregivers of children at risk preferred needle-free epinephrine, according to ...
SAN DIEGO, March 05, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves ...
Neffy nasal spray shows comparable efficacy to IM epinephrine for type I allergic reactions, with 92.3% symptom resolution after 1 dose.
Epinephrine improves ROSC in cardiac arrest but does not increase favorable neurologic recovery, raising ethical and ...
Five poster presentations highlight clinical advancement of neffy , real-world usability and advantages of needle-free epinephrine ...
SAN DIEGO — A nasal spray to treat patients in anaphylactic shock is now on the market and it was developed in our backyard. The epinephrine medication could replace the fear of using a needle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results